Actively Recruiting
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Led by University College, London · Updated on 2024-05-22
990
Participants Needed
6
Research Sites
142 weeks
Total Duration
On this page
Sponsors
U
University College, London
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to look at whether an Artificial Intelligence (AI) based computer program can automate two components of the radiotherapy treatment pathway to a sufficient quality standard to enable its routine clinical use. The two components include the delineation (outlining) of anatomical areas that are at risk of tumour spread and at risk of radiation damage, and the definition of the position, size and shape of the radiation beams. The AI-based computer programs have been developed to perform tasks that would normally require direct human involvement by oncologists and medical physicists. Proposed advantages include improved treatment accuracy, as well as a reduction in the time (from weeks to minutes) and human resources needed to deliver radiotherapy, which this study will test.
CONDITIONS
Official Title
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Patients with histologically confirmed head and neck cancers of the oropharynx, larynx, hypopharynx, or nasopharynx (Stage I-III) consenting to radical radiotherapy
- Patients with histologically confirmed primary cervical cancer (Stage IB-IIIB including pelvic node positive) consenting to radical radiotherapy
- Patients with histologically confirmed primary prostate cancer (T1-4N0M0) consenting to radical radiotherapy
- Mental capacity to understand and consent to participate in the study
You will not qualify if you...
- Patients requiring radiotherapy after curative or extensive tumor-removal surgery
- Patients receiving palliative radiotherapy
- Patients younger than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Tata Medical Centre
Kolkata, India
Actively Recruiting
2
Tata Memorial Hospital
Mumbai, India
Actively Recruiting
3
King Hussein Cancer Center
Amman, Jordan
Actively Recruiting
4
University of Malaya Medical Center
Kuala Lumpur, Malaysia
Actively Recruiting
5
Groote Schuur Hospital
Cape Town, South Africa
Actively Recruiting
6
Tygerberg Hospital
Stellenbosch, South Africa
Not Yet Recruiting
Research Team
A
ARCHERY Trial Manager
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here